Methamphetamine
N-methylamphetamine
Viewing r1 — Apr 21, 2026 — CURRENT
Back to HistoryInteractions, related substances, and reports reflect the current entry and are not shown for historical revisions.
Methamphetamine — meth, ice, crystal — is a synthetic stimulant of the phenethylamine class. It is the N-methylated form of amphetamine, more potent and longer-lasting. It floods the brain with dopamine and norepinephrine, producing the intense drive and wakefulness it is known for.[1][2]
Psychedex is in open beta. We are still fine-tuning the generation and review process. Please double-check sources.
amphetamine, cocaine, methylphenidate +1 moreamphetamine, cocaine, methylphenidate, MDMA show less
Nagayoshi Nagai first synthesized methamphetamine in 1893; Akira Ogata crystallized it in 1919.[3] Both sides in World War II distributed it as a combat stimulant; postwar surplus in Japan triggered the country's first major stimulant epidemic.[4] It is now Schedule II in the United States — marketed as Desoxyn — and illicit crystal methamphetamine is among the most widely used stimulants globally.[5]
Subjective effects include intense euphoria, wakefulness, appetite suppression, focused mental energy, and elevated heart rate. The experience is hard-edged and inward-directed — a driven, productive focus at lower doses that tips into compulsive restlessness at higher ones. Anxiety, paranoia, bruxism, and repetitive behavior are common undesired effects.
Methamphetamine carries extremely high addiction liability; chronic use structurally damages the brain's dopamine system, and cardiovascular harm — including stroke and heart muscle damage — is the primary physical risk.[6] The brain becomes more reactive to the drug over time, so even a small dose after abstinence can trigger paranoid psychosis.[7] It is extensively studied, but no approved medication for dependence exists.[8]
History[edit]
Discovery
Nagayoshi Nagai first synthesized methamphetamine from ephedrine in 1893.[3] Akira Ogata crystallized it in 1919 using a reduction method that still underlies clandestine production today.[3]
Military and pharmaceutical era
Both sides in World War II distributed methamphetamine — marketed as Pervitin in Germany and Philopon in Japan — as a wakefulness agent. When the war ended, surplus stocks flooded the Japanese civilian market and produced the country's first major stimulant epidemic, driving international drug control efforts.[4] A pharmaceutical form, Desoxyn, remains FDA-approved for ADHD.
Regulation and modern crisis
The 1971 United Nations Convention placed methamphetamine on Schedule II, permitting medical use under strict national controls.[4] Illicit production shifted from small domestic labs to industrial operations in Mexico and Southeast Asia, and crystal methamphetamine became a global public health crisis.[5]
The name "methamphetamine" traces its chemical structure: methyl-alpha-methyl-phenyl-ethyl-amine. Street names reflect form and geography — "ice" and "crystal" describe the translucent shards of the hydrochloride salt; "Tina" emerged from chemsex communities. The compound occupies an unusual position: a legally prescribed medication, a wartime drug distributed across multiple armies, and one of the most stigmatized illicit substances in public discourse.
Chemistry[edit]
Methamphetamine belongs to the substituted phenethylamine family, sharing its core scaffold with amphetamine.[3] Its molecular formula is C₁₀H₁₅N. An extra methyl group on the nitrogen atom increases fat solubility, allowing faster brain entry and greater potency than amphetamine.[3]
The active d-form (dextromethamphetamine) drives psychoactive effects; the inactive l-form appears in some over-the-counter nasal decongestants.[9] The compound distributes widely through body tissues including the brain.[10]
Pharmacology[edit]
Mechanism of action
Methamphetamine enters nerve terminals through the same transporters that normally recycle dopamine and norepinephrine. Once inside, it forces those transporters to run in reverse, flooding the synapse with both neurotransmitters.[11][2] The effect is strongest for dopamine and norepinephrine — serotonin release is much weaker, which sets it apart from MDMA.[1]
It also disrupts the storage vesicles inside the neuron that hold dopamine in reserve, releasing that stored dopamine where it then gets pumped outward — generating dopamine levels far beyond what transporter reversal alone would produce.[2][12]
Pharmacokinetics
The drug reaches the brain efficiently by any route: about 90% of a smoked dose absorbs, versus 67% orally.[10] A half-life of 10–12 hours accounts for the long duration of effects.[10] The liver converts it partly into amphetamine and an inactive metabolite; 37–45% leaves the body unchanged in urine.[10][3]
Neuroscience[edit]
Reward pathway and cognitive effects
Methamphetamine produces a massive surge of dopamine in the brain's reward circuit — the pathway from the ventral tegmental area to the nucleus accumbens. This overwhelms normal signaling and drives the intense reinforcement and compulsive use characteristic of methamphetamine disorder.[5]
Neurotoxicity and sensitization
Chronic use damages dopamine and serotonin nerve terminals. Excess dopamine in the cell generates toxic molecules; neuroinflammation amplifies the damage.[13][14] Brain scans confirm a 23–25% drop in DAT density in key motor regions after years of abstinence, alongside shrinkage in areas governing mood and memory.[7][15]
Rather than tolerance, repeated use creates behavioral sensitization — the brain grows more reactive to the drug's rewarding effects, not less.[16] Chronic users develop lasting vulnerability to paranoid episodes triggered by small doses or stress alone, even years after stopping.[17]
Subjective Effects[edit]
Methamphetamine produces a hard-edged, driven stimulation — focused and relentless. At lower doses, the dominant quality is clear-headed energy and urgency. That drive sharpens rather than eases as dose increases, tipping into compulsive restlessness and an inability to stop.
Compared to amphetamine, the experience is qualitatively similar but more intense and longer-lasting. Where MDMA creates warmth and dissolves the sense of distance between people, methamphetamine sharpens that distance. The result is an inward-directed focus that reads as productivity or anxious hypervigilance depending on context.
Effect Grid
At common doses (10–25 mg oral), the full stimulant experience is present: pronounced euphoria, significant energy and wakefulness, marked appetite suppression, and increased sociability. Thought acceleration is prominent — ideas come rapidly and may feel unusually clear or important. Motivation and confidence increase substantially. Some users report enhanced empathy and talkativeness at the lower end of this range.
Cardiovascular effects become significant: elevated heart rate (10–20 bpm above baseline), increased blood pressure, and peripheral vasoconstriction. Bruxism, dry mouth, and urinary retention are common. Body temperature may rise slightly. Sweating increases.
Sleep is impossible for 6–10 hours after oral dosing at this range. Appetite is profoundly suppressed. Functional activities requiring focus may feel enhanced, though complex decision-making can be impaired by overconfidence.
Modeled from the effect's dose-dependence curve — not per-substance measurements.
Sound sensitivity · Auditory enhancement · Visual haze / noise · Brightness alteration · Auditory misinterpretation · Peripheral misidentification · Visual drifting · Auditory distortion · Spatial disorientation · Auditory hallucinations · External hallucinations · Shadow people · Olfactory hallucination · Object transformations · Internal hallucinations · Persisting hallucinations
Auditory misinterpretation · Peripheral misidentification · Visual drifting · Auditory distortion · Spatial disorientation · Auditory hallucinations · External hallucinations · Shadow people · Olfactory hallucination · Object transformations · Internal hallucinations · Persisting hallucinations
Wakefulness · Dry mouth · Insomnia · Dehydration sensation · Excessive sweating · Muscle tension · Body high · Heart rate perception changes · Physical fatigue · Restlessness · Respiratory stimulation · Spontaneous body sensations · Temperature dysregulation · Bruxism · Sexual arousal enhancement · Constipation · Tactile euphoria · Tingling / electric sensations · Sexual arousal suppression · Headache · Nausea · Trembling · Vibrations / buzzing · Involuntary body movements · Seizure threshold reduction · Dizziness · Motor control impairment · Motor control enhancement · Vomiting · Tactile hallucination
Dehydration sensation · Excessive sweating · Muscle tension · Body high · Heart rate perception changes · Physical fatigue · Restlessness · Respiratory stimulation · Spontaneous body sensations · Bruxism · Sexual arousal enhancement · Constipation · Tactile euphoria · Tingling / electric sensations · Sexual arousal suppression · Headache · Nausea · Trembling · Vibrations / buzzing · Involuntary body movements · Seizure threshold reduction · Dizziness · Motor control impairment · Motor control enhancement · Vomiting · Tactile hallucination
Focus enhancement · Motivation enhancement · Motivation suppression · Cognitive dysphoria · Information processing enhancement · Cognitive impairment · Immersion enhancement · Aesthetic enhancement · Analysis enhancement · Novelty enhancement · Pattern recognition enhancement · Thought connectivity · Thought loops · Thought organization · Creativity enhancement · Language enhancement · Cognitive flexibility · Introspection enhancement · Multiple thought streams · Openness enhancement · Thought disorganization · Memory enhancement · Humor enhancement · Confusion · Delusions of sobriety · Information processing suppression · Memory fragmentation · Memory suppression · Suggestibility enhancement · Thought deceleration · Delusions · Delirium
Cognitive dysphoria · Information processing enhancement · Cognitive impairment · Immersion enhancement · Aesthetic enhancement · Analysis enhancement · Novelty enhancement · Pattern recognition enhancement · Thought connectivity · Thought loops · Thought organization · Creativity enhancement · Language enhancement · Cognitive flexibility · Introspection enhancement · Multiple thought streams · Openness enhancement · Thought disorganization · Memory enhancement · Humor enhancement · Confusion · Information processing suppression · Memory fragmentation · Memory suppression · Suggestibility enhancement · Thought deceleration · Delusions · Delirium
Anxiety · Dysphoria · Emotional enhancement · Emotional lability · Empathy enhancement · Suicidal ideation · Empathy suppression · Mania
Emotional lability · Empathy enhancement · Empathy suppression · Mania
Communication enhancement · Flow state · Sociability enhancement · Automaticity · Emotional susceptibility · Sociability suppression · Social connection · Social disconnection · Communication suppression · Trust enhancement · Self-control enhancement · Depersonalization · Derealization
Emotional susceptibility · Sociability suppression · Social connection · Social disconnection · Communication suppression · Trust enhancement · Self-control enhancement · Depersonalization · Derealization
Timeline
First alerts appear 15–30 minutes after ingestion: a subtle brightening of mood, mild increase in alertness, and faint body warmth. Effects are barely distinguishable from placebo at this stage.
Stimulation builds steadily over 30–90 minutes. Euphoria, increased energy, and appetite suppression become clearly perceptible. Heart rate rises.
Full stimulant intensity is sustained for 2–4 hours. Pronounced euphoria, wakefulness, thought acceleration, and sociability dominate. Cardiovascular activation is significant.
Effects gradually diminish but remain clearly present for 2–3 hours. Stimulation persists without the euphoric peak. Focus may narrow or become compulsive.
The comedown spans 1–2 hours. Fatigue, irritability, and mild depressed mood emerge as stimulant effects recede. Appetite begins to return.
Residual effects persist for 6–24 hours: mild fatigue, low mood, impaired concentration, and disturbed sleep architecture. Some individuals experience rebound hypersomnia and hyperphagia.
⚠ Do not drive or operate machinery during the comedown and afterglow period; stimulant-related fatigue and impaired reaction time persist well beyond the subjective experience.
Safety[edit]
- Acute toxicity
- High
- Chronic toxicity
- High
- Withdrawal
- Moderate
- Tolerance buildup
- rapid
- Tolerance reset
- 14 days
- Physical
- Moderate
- Psychological
- High
- Compulsive redosing
- High
- Dose escalation
- High
- Cross-tol.
- amphetamine · cocaine · methylphenidate
Toxicity
Acute toxicity
High doses produce dangerous overheating, severe blood pressure elevation, rapid heart rate, agitation, and seizures.[3] In one emergency department series, methamphetamine was implicated in 72% of agitated patient presentations.[19] No human lethal dose has been established — individual sensitivity varies enormously.safety citation needed
Heart and circulation
Cardiovascular complications are the second leading cause of death in methamphetamine users.[6] These include severe blood pressure elevation, heart muscle damage (partially reversible with abstinence), pulmonary arterial hypertension,[20] heart attacks, aortic tears, and abnormal heart rhythms.
Reduced activity of a liver enzyme may contribute to blood vessel damage through oxidative stress.[21]
Stroke
Methamphetamine is a significant cause of stroke in adults under 45.[22] Blood pressure spikes, vessel spasm, and drug-induced vessel inflammation all contribute.[23]
Brain damage
Chronic use produces lasting structural changes. Dopamine transporter density drops 23–25% in key motor regions.[7] Gray matter in emotional regulation areas shrinks 11.3%, the hippocampus 7.8%, and white matter changes of 7.0% are measurable[15] — all correlating with memory suppression that persists years into abstinence.
Reproductive toxicity
Prenatal exposure causes developmental delay, growth restriction, and sensorimotor deficits. Adverse outcomes have been documented in infants born to methamphetamine-using mothers.[24]
Psychological risks
High doses or prolonged use can produce paranoid delusions, hallucinations, and persecutory ideation. Acute episodes typically resolve on their own.[25]
The lasting risk is sensitization to psychosis: chronic use creates vulnerability with no established time limit. Even after years of abstinence, a small dose — or non-drug stressors like sleep deprivation — can trigger a full psychotic episode.[17][26] Persistent psychosis is associated with more severe cognitive impairment, suggesting it may mark underlying brain damage.[27]
Tolerance & dependence
Methamphetamine carries extremely high addiction liability.[5] Brain scans confirm lasting dopamine transporter reductions — structural nerve terminal damage, not reversible adaptation.[7] Cross-tolerance within the dopaminergic stimulant class is established.
Withdrawal brings depression, fatigue, heavy sleep, appetite enhancement, anhedonia, and cognitive impairment. No FDA-approved medication exists for methamphetamine dependence,[8][28] and the evidence base for withdrawal treatment remains poor.[29] Mirtazapine, naltrexone, and bupropion show potential;[30] the combination of extended-release naltrexone and bupropion has the strongest trial evidence to date.[31]
Drug interactions
Monoamine oxidase inhibitors
Combining methamphetamine with any MAOI — irreversible types like phenelzine or tranylcypromine, the reversible moclobemide, or herbal preparations like Syrian rue — can cause fatal blood pressure crisis, severe serotonin syndrome, and brain hemorrhage.[32] This combination is absolutely contraindicated.
Serotonergic agents
Methamphetamine releases serotonin, weakly. Combined with SSRIs, SNRIs, or tramadol, that additional serotonin load can push the body into a dangerous state — extreme overheating, muscle rigidity, and cardiovascular instability.[33] Tramadol additionally lowers the seizure threshold.safety citation needed
CYP2D6 inhibitors
Fluoxetine, paroxetine, bupropion, and quinidine slow the liver's breakdown of methamphetamine, raising blood levels and increasing cardiovascular and CNS toxicity risk.[3]
Other stimulants
Combining with MDMA, amphetamine, or cocaine adds cardiovascular strain — elevated blood pressure, rapid heart rate, and overheating — and amplifies neurotoxicity risk. Methamphetamine combined with MDMA carries particular concern for serotonin overload.
CNS depressants
Alcohol, GHB/GBL, and benzodiazepines can mask the severity of stimulant intoxication, delaying recognition of toxicity. In chemsex contexts, the stimulant effect may mask GHB's respiratory depression risk if GHB dosing is escalated.
Contraindications
Absolute
- Concurrent MAOI use: Fatal blood pressure crisis, serotonin toxicity, and brain hemorrhage are documented consequences[32]
- Severe heart or blood vessel disease: Including uncontrolled high blood pressure, heart muscle damage, recent heart attack, and aortic aneurysm[3]
- Overactive thyroid: Stimulant effects compound thyroid-mediated cardiovascular stress
- History of drug-induced psychosis: sensitization produces lasting vulnerability to psychotic recurrence[17]
- Glaucoma: pupil dilation and stimulant effects raise eye pressure
Relative
- History of abnormal heart rhythm or heart muscle damage: Noradrenergic effects worsen cardiac conduction problems
- Concurrent serotonergic medications: SSRIs, SNRIs, tramadol — serotonin syndrome risk[33]
- History of seizures: Methamphetamine lowers seizure threshold
- Pregnancy: Prenatal exposure associated with adverse outcomes[24]
- Bipolar disorder: Stimulant exposure may trigger manic episodes
Harm Reduction[edit]
Forms & Identification
Crystal methamphetamine's appearance — clear shards or white powder — gives no reliable information about purity or potency. Industrial-scale production has increased average purity in many markets, which narrows the margin for error in dose estimation by eye or weight.
Reagent testing confirms a methamphetamine-type compound is present but cannot identify which enantiomer or detect dangerous cutting agents at low concentrations. Use fentanyl test strips in any market where opioid contamination of the stimulant supply has been documented — even trace fentanyl can be fatal in someone without opioid tolerance.
Guidelines
- Test every batch with reagent kits and fentanyl test strips before use
- Start with the lowest effective dose and wait for full onset before redosing — oral onset requires 15–30 minutes
- Set a firm time limit for the session; methamphetamine's long duration makes it easy to extend use into multiple days
- Stay hydrated with water or electrolyte drinks — aim for regular sips rather than large volumes
- Eat before and during use; appetite suppression masks caloric need
- Avoid redosing to chase the initial rush — this is the pattern most associated with binge use and escalating toxicity
- Monitor body temperature; if overheated, cool down actively with cold water and air circulation
- Have a trusted person aware of the session who can check in
Set & Setting
Route of administration is the single most important risk modifier. Oral use produces gradual onset and manageable intensity. Smoked and injected routes deliver a rapid, intense rush that substantially increases addiction liability and cardiovascular strain. Choosing oral over non-oral routes is the most effective individual harm reduction decision for this substance.
A controlled, familiar setting with trusted people present reduces the likelihood of anxiety escalation and paranoid ideation. Sleep deprivation, dehydration, and high ambient temperature amplify both cardiovascular risk and psychological distress.
Aftercare & integration. The methamphetamine comedown is driven by dopamine depletion: expect low mood, fatigue, heavy sleep, appetite enhancement, and difficulty concentrating for 1–3 days — longer after extended binges. Sleep is the most important recovery tool. Do not use more methamphetamine to counteract the crash.
Eat nutrient-dense meals even when appetite is low; protein and complex carbohydrates support neurotransmitter recovery. Hydrate consistently. Avoid significant decisions during the acute comedown — anhedonia and cognitive fog distort judgment. If low mood persists beyond a week, or paranoid thinking does not fully resolve, seek professional evaluation.
Recovery & Support
Methamphetamine use disorder is among the most difficult addictions to treat, but recovery is achievable. No FDA-approved medication currently exists for dependence,[8] though extended-release naltrexone combined with bupropion has the strongest trial evidence to date.[31]
Behavioral therapies are the primary evidence-based approach: contingency management (incentive programs rewarding abstinence) and cognitive-behavioral therapy have the most consistent support. Crystal Meth Anonymous provides peer community structure during recovery.
Because of sensitization, any return to methamphetamine — even at small doses — carries risk of acute psychotic recurrence, potentially for life.[17] Anyone experiencing persistent psychosis, sustained depression, or inability to stop despite wanting to should seek professional help.
Recovery resources, crisis lines, and support pathways → View all
Emergency Response
Recognizing an emergency: chest pain, seizure, loss of consciousness, body temperature hot enough to feel through clothing, severe confusion, or psychotic behavior (threatening self or others) all require immediate medical attention. Anxiety, restlessness, and rapid heartbeat are uncomfortable but manageable — these other signs are not.
Immediate steps:
- 1. Call emergency services if anyone shows the above signs
- 2. Move the person to a cool, quiet environment
- 3. Remove excess clothing and apply cool water to skin if overheated
- 4. Do not physically restrain unless there is immediate danger of self-harm or harm to others
- 5. If the person is unconscious, place in the recovery position (on their side) and monitor breathing
- 6. Do not induce vomiting
What to tell the dispatcher: Name the substance (methamphetamine), estimated amount and time of use, and current symptoms. Good Samaritan laws in many jurisdictions protect people who call for help during a drug emergency.
Legal Status[edit]
Methamphetamine is internationally controlled under the 1971 United Nations Convention on Psychotropic Substances — recognized for high abuse potential while permitting medical use under strict national controls.[4]
| Jurisdiction | Classification | Key provisions |
|---|---|---|
| United States | Schedule II (Controlled Substances Act) | High abuse potential with accepted medical use. Desoxyn FDA-approved for ADHD and short-term obesity. Severe federal penalties for non-medical manufacture, distribution, and possession.[34] |
| United Kingdom | Class A (Misuse of Drugs Act 1971) | Highest restriction tier. Maximum penalties: life imprisonment for supply/production; 7 years for possession.[34] |
| Canada | Schedule I (CDSA) | No authorized pharmaceutical use. Maximum criminal penalties for trafficking, production, and import/export.[35] |
| Australia | Schedule 8 (SUSMP) | Controlled medicine requiring prescription with strict prescribing and dispensing requirements.[34] |
| European Union | Varies by member state | Member states implement the 1971 Convention individually. Not approved for medical use in EU. Classification generally equivalent to Schedule I or Class A. |
| International | Schedule II (1971 UN Convention) | Permits medical use under national control with international manufacturing and trade restrictions.[4] |
Legal status varies by jurisdiction and changes frequently. This information is for harm reduction purposes only and does not constitute legal advice.
references
- [1]
- [2] ^abcSulzer D, Chen TK, Lau YY, Kristensen H, Rayport S, Ewing A (1995) Amphetamine redistributes dopamine from synaptic vesicles to the cytosol and promotes reverse transport — Journal of Neuroscience PMID:7751968
- [3]
- [4]
- [5] ^abcdCourtney KE, Ray LA (2014) Methamphetamine: an update on epidemiology, pharmacology, clinical phenomenology, and treatment literature — Drug and alcohol dependence doi:10.1016/j.drugalcdep.2014.08.003
- [6] ^abParatz ED, Cunningham NJ, MacIsaac AI (2016) The Cardiac Complications of Methamphetamines — Heart, Lung and Circulation doi:10.1016/j.hlc.2015.10.019